| Literature DB >> 30319684 |
Megan K Mulligan1, Wenyuan Zhao1, Morgan Dickerson1, Danny Arends2, Pjotr Prins3, Sonia A Cavigelli4, Elena Terenina5, Pierre Mormede5, Lu Lu1, Byron C Jones1.
Abstract
We profiled individual differences in alcohol consumption upon initial exposure and during 5 weeks of voluntary alcohol intake in female mice from 39 BXD recombinant inbred strains and parents using the drinking in the dark (DID) method. In this paradigm, a single bottle of 20% (v/v) alcohol was presented as the sole liquid source for 2 or 4 h starting 3 h into the dark cycle. For 3 consecutive days mice had access to alcohol for 2 h followed by a 4th day of 4 h access and 3 intervening days where alcohol was not offered. We followed this regime for 5 weeks. For most strains, 2 or 4 h alcohol intake increased over the 5-week period, with some strains demonstrating greatly increased intake. There was considerable and heritable genetic variation in alcohol consumption upon initial early and sustained weekly exposure. Two different mapping algorithms were used to identify QTLs associated with alcohol intake and only QTLs detected by both methods were considered further. Multiple suggestive QTLs for alcohol intake on chromosomes (Chrs) 2, 6, and 12 were identified for the first 4 h exposure. Suggestive QTLs for sustained intake during later weeks were identified on Chrs 4 and 8. Thirty high priority candidate genes, including Entpd2, Per3, and Fto were nominated for early and sustained alcohol intake QTLs. In addition, a suggestive QTL on Chr 15 was detected for change in 2 h alcohol intake over the duration of the study and Adcy8 was identified as a strong candidate gene. Bioinformatic analyses revealed that early and sustained alcohol intake is likely driven by genes and pathways involved in signaling, and/or immune and metabolic function, while a combination of epigenetic factors related to alcohol experience and genetic factors likely drives progressive alcohol intake.Entities:
Keywords: B6; BXD; D2; DID; QTL; alcohol intake; alcoholism; genetic variation
Year: 2018 PMID: 30319684 PMCID: PMC6167410 DOI: 10.3389/fgene.2018.00370
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Anova results table.
| 2 h access | 4 h access | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Strain Effect | W1D1 | W1avg | W2avg | W3avg | W4avg | W5avg | W1D4 | W2D4 | W3D4 | W4D4 | W5D4 |
| 1.20E-09 | <2.20E-16 | <2.20E-16 | <2.20E-16 | <2.20E-16 | <2.20E-16 | 1.22E-11 | 1.69E-13 | 2.89E-15 | 3.80E-08 | 2.06E-12 | |
| 3.36 | 5.19 | 4.91 | 7.89 | 5.48 | 6.69 | 3.79 | 4.19 | 4.6 | 3.0 | 3.962 | |
| Df | 39 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |
| h2 | 0.29 | 0.39 | 0.37 | 0.49 | 0.40 | 0.45 | 0.32 | 0.34 | 0.36 | 0.27 | 0.33 |
Change in 2 and 4 h alcohol intake over 5-week.
| 2 h | 4 h | |||||
|---|---|---|---|---|---|---|
| Strain | Slope | Intercept | SE | Slope | Intercept | SE |
| BXD40 | 1.54 | 0.07 | 0.541 | 3.05 | 0.54 | |
| BXD24 | 1.51 | 0.07 | 0.545 | 3.20 | 0.55 | |
| C57BL/6J | 0.278 | 3.20 | 0.11 | -0.077 | 6.60 | -0.08 |
| BXD49 | 2.48 | 0.03 | -0.455 | 6.01 | -0.46 | |
| BXD34 | 1.16 | 0.04 | 2.46 | 0.41 | ||
| BXD68 | 0.218 | 2.09 | 0.07 | -0.002 | 4.96 | 0.00 |
| BXD50 | 1.18 | 0.01 | 2.83 | 0.23 | ||
| BXD77 | 1.22 | 0.02 | 2.47 | 0.37 | ||
| BXD83 | 1.50 | 0.03 | 3.02 | 0.41 | ||
| BXD62 | 1.57 | 0.03 | 0.153 | 3.59 | 0.15 | |
| BXD90 | 1.93 | 0.03 | 0.188 | 4.05 | 0.19 | |
| BXD73a | 1.95 | 0.01 | 3.80 | 0.36 | ||
| BXD75 | 1.21 | 0.04 | 0.198 | 2.62 | 0.20 | |
| BXD100 | 1.57 | 0.04 | 0.139 | 3.54 | 0.14 | |
| BXD70 | 0.160 | 2.23 | 0.06 | 0.132 | 4.88 | 0.13 |
| BXD98 | 0.150 | 4.28 | 0.30 | -0.318 | 6.87 | -0.32 |
| BXD73b | 1.58 | 0.01 | 3.04 | 0.32 | ||
| BXD78 | 2.61 | 0.03 | 5.72 | 0.19 | ||
| BXD71 | 1.91 | 0.03 | 0.272 | 4.37 | 0.27 | |
| BXD60 | 1.75 | 0.02 | 3.81 | 0.15 | ||
| BXD65b | 1.96 | 0.04 | -0.109 | 4.42 | -0.11 | |
| BXD48 | 2.76 | 0.02 | 5.02 | 0.54 | ||
| BXD44 | 0.127 | 1.74 | 0.06 | 0.296 | 2.91 | 0.30 |
| BXD101 | 0.125 | 2.19 | 0.06 | 0.355 | 3.85 | 0.35 |
| BXD87 | 0.120 | 1.58 | 0.04 | 3.23 | 0.22 | |
| BXD73 | 0.118 | 1.94 | 0.04 | 0.060 | 4.28 | 0.06 |
| BXD65 | 1.73 | 0.03 | 0.232 | 3.36 | 0.23 | |
| BXD61 | 0.109 | 1.21 | 0.08 | -0.372 | 3.90 | -0.37 |
| BXD43 | 1.83 | 0.03 | 3.39 | 0.29 | ||
| BXD102 | 0.103 | 1.14 | 0.19 | 0.183 | 1.84 | 0.18 |
| BXD86 | 2.09 | 0.03 | 0.218 | 4.13 | 0.22 | |
| BXD69 | 2.03 | 0.03 | 0.197 | 3.58 | 0.20 | |
| BXD55 | 0.088 | 1.79 | 0.04 | 0.122 | 3.17 | 0.12 |
| BXD51 | 0.080 | 2.36 | 0.03 | 0.379 | 4.08 | 0.38 |
| BXD66 | 0.047 | 2.47 | 0.03 | 0.085 | 4.33 | 0.09 |
| BXD32 | 0.018 | 1.61 | 0.01 | 0.075 | 2.73 | 0.07 |
| BXD4S | 0.007 | 2.56 | 0.21 | -0.356 | 5.57 | -0.36 |
| BXD79 | -0.017 | 2.61 | 0.03 | -0.080 | 5.25 | -0.08 |
| BXD63 | -0.026 | 2.25 | 0.05 | -0.125 | 4.52 | -0.13 |
| DBA/2J | -0.041 | 2.17 | 0.09 | -0.040 | 4.32 | -0.04 |
| BXD48a | -0.046 | 2.89 | 0.05 | -0.264 | 5.72 | -0.26 |
Suggestive QTL detected by multiple mapping methods.
| Time | Method | Chr | Locus | Mb | Additive Effect | LOD | CIMb (left) | CIMb (right) |
|---|---|---|---|---|---|---|---|---|
| 2 | ||||||||
| 2 | ||||||||
Prioritized QTL candidate genes.
| Symbol | Description | Gene Wiki | QTL | HIP:Mean Expr | HIP:cis eQTL | HIP:Trait Correlation |
|---|---|---|---|---|---|---|
| Dnajc1 | DnaJ (Hsp40) homolog. subfamily C, member 1 | GRP78 partner in ER; translation, beneficial effects in ER stress induced metabolic dysfunction | Q2: Initial | 8.74 | Sug | – |
| armadillo repeat containing 3 | ? | Q2: Initial | Sig | – | ||
| Rho GTPase activating protein 21 | Signaling | Q2: Initial | 11.76 | Sig | Sig | |
| G protein-coupled receptor 158 | Regulator of RGS complexes and Rgs7 signaling in brain; human variants may influence energy expenditue and metabolism | Q2: Initial | 6.51 | Sig | Sig | |
| Myosin IIIA | Acin based motor protein with kinase activity | Q2: Initial | 6.35 | – | Sig | |
| Mitochondrial ribosomal protein L41 | Regulation of cell death | Q2: Initial | 10.29 | Sig | Sig | |
| UDP-N-acetylglucosamine pyrophorylase 1 like 1 | ? | Q2: Initial | 9.01 | Sig | – | |
| Ectonucleoside triphosphate diphosphohydrolase 2 | Metabolism | Q2: Initial | 9.72 | Sig | Sig | |
| Prostaglandin D2 synthase | Glucose and insulin metabolism; regulated by estradiol; inflammatory response | Q2: Initial | 13.90 | Sig | – | |
| Complement component 8, gamma subunit | Immune function | Q2: Initial | 7.13 | Sig | – | |
| Potassium channel, subfamily T, member 1 (slack, low threshold slowly adapting) | Localized to the postsynaptic density; involved in learning and memory and initial response to novel situations and environments | Q2: Initial | 8.98 | Sig | – | |
| LIM homeobox protein 3 | Trancription factor activity, nervous system development | Q2: Initial | 6.23 | – | Sig | |
| EGF-like domain 7 | Development | Q2: Initial | 7.81 | Sug | – | |
| Rap guanine nucleotide exchange factor (GEF) 1 | Signaling; GABAergic neuronal development | Q2: Initial | 7.41 | Sug | Sig | |
| Nucleoporin 188 | Development | Q2: Initial | 8.50 | – | Sig | |
| plexin A1 | Development; signaling | Q6: Initial | 9.77 | Sig | – | |
| FYVE, RhoGEF and PH domain containing 5 | Endothelial specific gene | Q6: Initial | 8.00 | – | Sig | |
| A disintegrin-like and metalloprotease (reprolysin type} with thrombospondin type 1 motif, 9 | Endothelial and vascular response | Q6: Initial | 9.38 | Sug | Siq | |
| 5′-nucleotidase, cytosolic 1B | Metabolism | Q12: Initial | 7.18 | Sug | Sig | |
| Period 3 | Circadian signaling | Q4: Sustained | 7.11 | Sig | Sig | |
| PR domain containing 16 | Metabolism; brown versus white fat differentiation | Q4: Sustained | 6.52 | Sig | Sig | |
| Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | Inflammation and immune response | Q4: Sustained | Sig | – | ||
| Cylindromatosis (turban tumor syndrome} | Immune; regulator of NF-kappaB signaling | Q8: Sustained | 10.41 | Sig | Sig | |
| Chromodomain helicase DNA binding protein 9 | Expressed in osteoprogenitors | Q8: Sustained | 9.55 | Sig | – | |
| AKT interacting protein | Ft1 protein; telomere maintenance; development | Q8: Sustained | 7.49 | Sig | Sig | |
| Fat mass and obesity associated (alpha-ketoglutarate-dependent dioxygenase FTO) | Metabolism; energy homeostasis; regulator of adipogenesis | Q8: Sustained | 6.94 | Sig | Sig | |
| Colorectal neoplasia differentially expressed (non-protein coding} | Metabolism; control of glucose and lipid metabolism | Q8: Sustained | 6.63 | Sig | Sig | |
| Matrix metaloproteinase 2 | Immune system; inflammatory response | Q8: Sustained | 6.66 | Sig | Sig | |
| Coenzyme QB | Metabolism: deficiency impacts mitochondrial function | Q8: Sustained | 10.49 | Sig | Sig | |
| Kinesin family member C3 | Peroxisomal transport | Q8: Sustained | 10.01 | Sig | Sig |